Nafamostat mesilate (NM), a protease inhibitor, possesses a cytoprotective effect and inhibits the activation of complement. The present study investigated whether NM has any protective effect against injury of porcine hepatocytes by human plasma in a bioartificial liver support system. Porcine hepatocytes were har vested and seeded at a density of 2 x 10 5 cells on a 35-mm collagen-coated plate in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum. Twenty-four hours later, the medium was replaced with human plasma with three concentrations of NM between 3.8 x 10~5 and 3.8 x W 4 M and then cultured for 6 h. The viability of porcine hepatocytes, lactate dehydrogenase (LDH) levels, lidocaine clearance, por cine albumin production, and changes in complement (C3) levels were measured. The viability of porcine hepatocytes in human plasma decreased significantly to 37.7 + 11.4% of that in DMEM. NM improved the viability of the hepatocytes, lowered the levels of LDH, and increased lidocaine clearance and albumin production in a concentration-dependent manner. The concentrations of C3, the marker of xenogeneic reac tions, did not change significantly, indicating that no hyperacute xenogeneic reaction occurred in our series. Together, our results suggested that NM exerts favorable effects on porcine hepatocytes in human plasma through direct effect such as prevention of protease activity in the plasma membrane of porcine hepatocytes rather than inhibition of complement-dependent immunoreactions.
INTRODUCTION
Fulminant hepatic failure (FHF) is a therapeutic chal lenge. At present, extracorporeal artificial liver supports, including plasma exchange (PE), charcoal hemoperfusion, and hemofiltration/hemodiafiltration, are clinically available to treat patients with FHF (11, 13) . However, the effectiveness of these modalities has been transitory, limited, or both.
The development of bioartificial livers (BAL) using porcine hepatocytes has been proceeding (8, 16, 21, 23) , and the clinical results are encouraging (27) . We have developed a BAL system based on the method described by Rozga et al. (20, 21) , using porcine hepatocytes. One of the most formidable limiting factors in such BAL sys tems is injury to the porcine hepatocytes by human plasma (4, 20, 27) . Xenogeneic reactions of immunoglob ulins such as IgM in human plasma and degradation of the lysosomal membrane proteins by trypsin-like prote ase (15) are considered possible mechanism in such situ ations. Nafamostat mesilate (NM; 6-amino-2-naphthyl-p-gu-anidino-benzoate dimethane-sulfonate) is a synthetic in hibitor of serine proteases, which reportedly inhibits several steps of the complement cascade, as well as plasmin, plasma kallikrein, thrombin, and trypsin (3, 14) . In addition, it inhibits superoxide (7, 25) , so that the integ rity of the cell membrane is maintained (2, 12) .
The purposes of the present study are to investigate the reaction between porcine hepatocytes and human plasma, and to evaluate the efficacy of NM in protecting porcine hepatocytes from cytotoxicity of human plasma.
MATERIALS AND METHODS
All study protocols were reviewed and approved by 
Human Plasma
Frozen human plasma was generously provided by the Japanese Red Cross Society (Tokyo, Japan).
Cell Cultures
Hepatocytes were seeded on collagen-coated, 35-mm, six-well Microplates (Iwaki Glass Inc., Chiba, Japan) at a density of 2 x 10 s cells per plate in 2 ml of DMEM with 10% FCS. The medium was replaced 4 h later and was incubated for 20 h in an atmosphere of 95% 0 2 and 5% C0 2 at 37°C.
Experimental Groups
Twenty-four hours after seeding, the medium was re placed by DMEM or human plasma with different con centrations of NM (none, 3.8 xlO" 4 , 1.9x10"*, 3.8 x 
Statistical Analysis
Data were expressed as means ± SD and analyzed sta tistically using one-way analysis of variance (ANOVA).
A value of p < 0.05 was considered as significant.
RESULTS

Viability of Hepatocytes
Total disruption of porcine livers by collagenase reperfusion allowed the harvest of 1-2 ± 10 10 hepatocytes with an initial viability constantly greater than 95%, as estimated by the trypan blue exclusion test. The viability of the porcine hepatocytes in the microplate after treat ment is shown in Figure 1 . The results are reported as percent viability compared with the DMEM group. That of porcine hepatocytes in the HP group was much lower than that in the DMEM group (37.7 ± 11.4%). NM im proved the viability concentration dependently, and that in the NM-1 group was significantly higher than that in the HP group (48.1 ± 12.2% vs. 37.7 ± 11.4%) (p < 0.05).
Levels of LDH
The level of LDH in the NM-1 culture medium was significantly lower than that in the HP group (p < 0.05, Table 1 ). Moreover, there was a significant difference in LDH level between groups NM-1 and NM-3 (p < 0.05).
The levels of AST and ALT in culture media were concentration-dependently lower in the NM groups than in the HP group, but no significant differences were noted ( Table 1) .
Synthesis of Porcine Albumin
The levels of porcine albumin are shown in Figure 2 . Albumin levels were increased concentration depen dently by addition of NM, with a statistical significance between the HP and NM-1 groups (1.71 + 0.8 x 10 3 ng/ pi vs. 3.01 ± 1.01 x 10~3 ng/ul, respectively; p < 0.05 ). clearance was 0.03710.019 ug/ml/min. On the other hand, the lowest removal rate was found in the HP group, where the concentration of lidocaine decreased from 10 ug/ml to 8.35 ± 0.82 ug/ml for 60 min and lido caine clearance was 0.02510.015 ug/ml/min. In the NM groups, the lidocaine-removing ability improved concentration dependently in comparison with that in the HP group.
Lidocaine Clearance
Levels of Complement (C3)
The levels of complement (C3) in human plasma did not changed significantly in any groups over the period of incubation with porcine hepatocytes (Fig. 4) .
DISCUSSION
For the hepatocyte-based bioartificial liver (BAL) to be effective for long-term treatment, cellular injury of hepatocytes in BAL by human plasma should be re duced. The major cause of functional deterioration of a hepatocyte-based BAL is the injury to hepatocytes in human plasma, due to the environment, presumably un favorable to porcine cells, which contains hepatotoxins and unusual nutrients with abnormal pH and osmolarity levels, and which may be the site of xenogeneic immunoreactions. In order to overcome these unfavorable conditions, we evaluated the efficacy of NM in the pro- tection of porcine hepatocytes. NM is a synthetic inhibi tor of serine protease that has several beneficial effects for cells and tissues (5, 10, 17) .
It has been reported (5, 17) NM also has some other functions, including inhibi tion of the trypsin-like protease that is located on the cell membranes of hepatocytes (15, 26) , as well as super oxide production (7, 25) . We presumed that the reason for the improved viability of porcine hepatocytes caused by NM was not the suppression of a xenogeneic reac tion. Although it cannot be ruled out that NM inhibits superoxide or other factors, NM may have functioned as a membrane protector. The possible mechanisms are: a) inhibition of trypsin-like protease (15) that is located on the hepatocyte cell membrane and plays a role in the regulation of integral membrane protein turnover, b) lysing by trypsin of components of the extracellular matrix such as fibronectin, which is involved in the attachment and extension of isolated cultured hepatocytes to make cell-to-cell contact (25) . NM can reduce the effect of trypsin, leading to better cell-to-cell contact.
In conclusion, the present study demonstrated that NM had a beneficial effect on porcine hepatocytes in human plasma, not through the inhibition of comple ment-dependent immunoreactions, but rather through di rect effects such as prevention of trypsin-like protease activity in hepatocytes. Thus, this agent could be utilized as a cytoprotective agent when porcine hepatocytes are to be used in hepatocyte-based BAL system.
